These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2169923)

  • 1. Factor IXHollywood: substitution of Pro55 by Ala in the first epidermal growth factor-like domain.
    Spitzer SG; Kuppuswamy MN; Saini R; Kasper CK; Birktoft JJ; Bajaj SP
    Blood; 1990 Oct; 76(8):1530-7. PubMed ID: 2169923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and theoretical evidence supporting the role of Gly363 in blood coagulation factor IXa (Gly193 in chymotrypsin) for proper activation of the proenzyme.
    Bajaj SP; Spitzer SG; Welsh WJ; Warn-Cramer BJ; Kasper CK; Birktoft JJ
    J Biol Chem; 1990 Feb; 265(5):2956-61. PubMed ID: 2303434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX.
    Ludwig M; Sabharwal AK; Brackmann HH; Olek K; Smith KJ; Birktoft JJ; Bajaj SP
    Blood; 1992 Mar; 79(5):1225-32. PubMed ID: 1346975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.
    Larson PJ; Stanfield-Oakley SA; VanDusen WJ; Kasper CK; Smith KJ; Monroe DM; High KA
    J Biol Chem; 1996 Feb; 271(7):3869-76. PubMed ID: 8632006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
    Astermark J; Sottile J; Mosher DF; Stenflo J
    J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
    J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B.
    Lozier JN; Monroe DM; Stanfield-Oakley S; Lin SW; Smith KJ; Roberts HR; High KA
    Blood; 1990 Mar; 75(5):1097-104. PubMed ID: 2306516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
    Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
    J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor IX Amagasaki: a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities.
    Miyata T; Sakai T; Sugimoto M; Naka H; Yamamoto K; Yoshioka A; Fukui H; Mitsui K; Kamiya K; Umeyama H
    Biochemistry; 1991 Nov; 30(47):11286-91. PubMed ID: 1958666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor IX Fukuoka. Substitution of ASN92 by His in the second epidermal growth factor-like domain results in defective interaction with factors VIIa/X.
    Nishimura H; Takeya H; Miyata T; Suehiro K; Okamura T; Niho Y; Iwanaga S
    J Biol Chem; 1993 Nov; 268(32):24041-6. PubMed ID: 8226948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins.
    Spitzer SG; Warn-Cramer BJ; Kasper CK; Bajaj SP
    Biochem J; 1990 Jan; 265(1):219-25. PubMed ID: 2105717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IXa beta. Effects on the serine protease module and factor X activation.
    Astermark J; Hogg PJ; Stenflo J
    J Biol Chem; 1994 Feb; 269(5):3682-9. PubMed ID: 8106413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain.
    McCord DM; Monroe DM; Smith KJ; Roberts HR
    J Biol Chem; 1990 Jun; 265(18):10250-4. PubMed ID: 2355000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain.
    Christophe OD; Lenting PJ; Kolkman JA; Brownlee GG; Mertens K
    J Biol Chem; 1998 Jan; 273(1):222-7. PubMed ID: 9417068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.
    Bertina RM; van der Linden IK; Mannucci PM; Reinalda-Poot HH; Cupers R; Poort SR; Reitsma PH
    J Biol Chem; 1990 Jul; 265(19):10876-83. PubMed ID: 2162822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor IX Bm Kiryu: a Val-313-to-Asp substitution in the catalytic domain results in loss of function due to a conformational change of the surface loop: evidence obtained by chimaeric modelling.
    Miyata T; Kuze K; Matsusue T; Komooka H; Kamiya K; Umeyama H; Matsui A; Kato H; Yoshioka A
    Br J Haematol; 1994 Sep; 88(1):156-65. PubMed ID: 7803238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular defect in factor IX Tokyo: substitution of valine-182 by alanine at position P2' in the second cleavage site by factor XIa resulting in impaired activation.
    Maekawa H; Sugo T; Yamashita N; Kamiya K; Umeyama H; Miura N; Naka H; Nishimura T; Yoshioka A; Matsuda M
    Biochemistry; 1993 Jun; 32(24):6146-51. PubMed ID: 8512923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine 69 of the first epidermal growth factor-like domain of human factor IX is essential for clotting activity.
    Hughes PE; Morgan G; Rooney EK; Brownlee GG; Handford P
    J Biol Chem; 1993 Aug; 268(24):17727-33. PubMed ID: 8349658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia B Durham: a mutation in the first EGF-like domain of factor IX that is characterized by polymerase chain reaction.
    Denton PH; Fowlkes DM; Lord ST; Reisner HM
    Blood; 1988 Oct; 72(4):1407-11. PubMed ID: 3262389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three novel and one C31133T (Arg-338-->Stop) mutations of antihemophilic factor IX gene detected in Taiwan.
    Young JH; Wang JC; Lin YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):241-6. PubMed ID: 8705874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.